Edwards Lifesciences (EW)

CapEx to Revenue

3.84%

Quarterly · Period ending:

EW logo

EW CapEx to Revenue

Latest reported3.84%
EW Quarterly CapEx/Revenue (4.70% → 3.84%)
High-resolution chart · PNG

EW capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
3.8426%
3.9367%
6.2054%
3.7023%
3.2176%
3.964%
3.5936%
2.3553%
6.1621%
6.414%
8.0227%
4.4475%
3.6974%
4.2135%
6.6083%
4.5413%
3.1371%
5.4205%
7.0542%
4.6329%
5.0363%
8.7128%
9.5242%
9.0543%
11.7081%
7.2827%
6.0898%
6.9561%
6.6059%
5.9416%
6.1982%
9.0558%
5.595%
5.1632%
5.8413%
5.2708%
7.3295%
2.1053%
8.2324%
6.5323%
10.299%
3.9725%
6.1541%
4.2242%
2.9831%
3.5236%
7.3301%
2.9799%
2.7821%
2.7374%
3.8433%
7.5868%
5.5878%
4.6306%
10.9305%
5.7379%
5.8506%
3.9199%
8.7634%
4.725%
4.4527%
3.5105%
5.5301%
4.7005%
4.299%
2.7019%
6.8359%
3.7151%
5.0969%
3.5407%
14.4333%
4.0184%
3.663%
3.066%
6.2799%
6.0061%
5.4292%
5.1496%
6.5512%
7.2757%
5.9858%
3.1128%
8.7705%
4.4832%
3.7955%
2.4087%
8.3087%
3.5142%
3.7937%
2.5532%
5.2655%
4.5124%
12.6722%
3.6706%
7.7794%
5.1267%
5.0926%
4.6827%
6.1914%
6.2923%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.